INDIAN BENCHMARKS are likely to open on a cautious note as the global cues look mixed with SGX Nifty trading 12.50 points lower.
Headlines for the day:
- Aurobindo Pharma receives USFDA approval for anti-epileptic drug
- Biocon's arm Syngene International gets SEBI approval for IPO
- TVS Srichakra extends gain on ties up with France's Michelin
CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. CapitalStars also aveliable on social network
CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX.